XML 28 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Total Stockholders' Equity
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2013   4,467,614            
Beginning balance at Dec. 31, 2013 $ (99,480) $ 38 $ 1,614 $ (95,476) $ (5,656) $ 0 $ (99,480) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with IPO, net of underwriting discounts (in shares)   11,500,000            
Issuance of common stock in connection with IPO, net of underwriting discounts 209,990 $ 57 209,933       209,990  
Stock-based compensation 3,095   3,095       3,095  
Conversion of preferred stock warrants to common stock warrants upon IPO 4,912   4,912       4,912  
Conversion of preferred stock to common stock (in shares)   47,457,356            
Conversion of preferred stock to common stock 221,504 $ 237 221,267       221,504  
Vesting of restricted stock units (in shares)   11,667            
Vesting of restricted stock units 6   6       6  
Issuance of common stock warrant 64   64       64  
Exercise of stock options and warrants (in shares)   5,596,181            
Exercise of stock options and warrants 2,106 $ 28 2,078       2,106  
Accretion of dividends on redeemable convertible preferred stock (12,884)     (12,884)     (12,884)  
Net income (loss) (18,708)     (18,708)     (18,708)  
Ending balance (in shares) at Dec. 31, 2014   69,032,818            
Ending balance at Dec. 31, 2014 310,605 $ 360 442,969 (127,068) (5,656) 0 310,605 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 10,750   10,750       10,750  
Vesting of restricted stock units (in shares)   88,124            
Vesting of restricted stock units 41 $ 1 40       41  
Accretion of dividends on redeemable convertible preferred stock 0              
Investments by noncontrolling interests 7,873           0 7,873
Exercise of stock options (in shares)   747,224            
Exercise of stock options 214 $ 4 210       214  
Employee stock purchase plan (in shares)   202,732            
Employee stock purchase plan 3,244 $ 1 3,243       3,244  
Repurchases of common stock (in shares)   (10,690)            
Repurchases of common stock (187)       (187)   (187)  
Other comprehensive Income (678)         (372) (372) (306)
Other (209)   (209)       (209)  
Net income (loss) $ (2,231)     (1,273)     (1,273) (958)
Ending balance (in shares) at Dec. 31, 2015 70,060,208 70,060,208            
Ending balance at Dec. 31, 2015 $ 329,422 $ 366 457,003 (128,341) (5,843) (372) 322,813 6,609
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock-based compensation 17,385   17,385       17,385  
Accretion of dividends on redeemable convertible preferred stock $ 0              
Exercise of stock options (in shares) 559,034              
Employee stock purchase plan (in shares)   456,008            
Employee stock purchase plan $ 2,943 $ 2 2,941       2,943  
Repurchases of common stock (in shares)   (148,477)            
Repurchases of common stock (854)       (854)   (854)  
Issuance of common stock through vesting of restricted stock units and option exercises (in shares)   1,237,969            
Issuance of common stock through vesting of restricted stock units and option exercises 203 $ 6 197       203  
Other comprehensive Income (20)         (7) (7) (13)
Net income (loss) $ (85,482)     (82,958)     (82,958) (2,524)
Ending balance (in shares) at Dec. 31, 2016 71,605,708 71,605,708            
Ending balance at Dec. 31, 2016 $ 263,597 $ 374 $ 477,526 $ (211,299) $ (6,697) $ (379) $ 259,525 $ 4,072